Olema Pharmaceuticals, Inc. Common Stock OLMA
$7.82
+0.00%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $40.67
- Implied Upside
- +420.0%
- Price Target Range
- $27.00 – $59.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-14 | StifelLaura Prendergast |
Maintains | Buy | $48 → $30 |
| 2026-08-13 | JP MorganAnupam Rama |
Maintains | Overweight | $52 → $46 |
| 2026-08-11 | CitigroupYigal Nochomovitz |
Maintains | Buy | $62 → $59 |
| 2026-08-11 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $38 → $36 |
| 2026-05-13 | GuggenheimBrad Canino |
Maintains | Buy | $38 → $35 |
| 2026-03-27 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2026-03-19 | JefferiesDennis Ding |
Assumes | Buy | $43 → $40 |
| 2026-03-18 | JP MorganAnupam Rama |
Maintains | Overweight | $55 → $58 |
| 2026-03-18 | Goldman SachsRichard Law |
Maintains | Buy | $38 → $27 |
| 2026-03-17 | CitigroupYigal Nochomovitz |
Maintains | Buy | $60 → $62 |
| 2026-03-17 | GuggenheimBrad Canino |
Maintains | Buy | $40 → $38 |
| 2026-03-09 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $36 → $38 |
| 2026-02-11 | StifelLaura Prendergast |
Initiates coverage on | Buy | $48 |
| 2026-01-07 | UBSMichael Yee |
Initiates coverage on | Buy | $45 |
| 2026-01-07 | Piper Sandler |
Initiates coverage on | Overweight | — |
| 2025-12-12 | CitigroupYigal Nochomovitz |
Maintains | Buy | $21 → $60 |
| 2025-12-11 | OppenheimerMatthew Biegler |
Maintains | Outperform | $45 → $48 |
| 2025-12-11 | Goldman SachsRichard Law |
Maintains | Buy | $26 → $38 |
| 2025-12-11 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $36 → $45 |
| 2025-11-21 | Goldman SachsRichard Law |
Maintains | Buy | $18 → $26 |
| 2025-11-18 | OppenheimerMatthew Biegler |
Maintains | Outperform | $22 → $45 |
| 2025-11-18 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $28 → $36 |
| 2025-11-18 | JP MorganAnupam Rama |
Maintains | Overweight | $29 → $32 |
| 2025-10-20 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $28 |
| 2025-10-08 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $20 |
| 2025-09-03 | OppenheimerMatthew Biegler |
Maintains | Outperform | $22 |
| 2025-08-14 | JP MorganAnupam Rama |
Maintains | Overweight | $28 → $29 |
| 2025-08-12 | CitigroupYigal Nochomovitz |
Maintains | Buy | $20 → $21 |
| 2025-05-14 | Goldman SachsRichard Law |
Maintains | Buy | $20 → $18 |
| 2025-05-14 | OppenheimerMatthew Biegler |
Maintains | Outperform | $25 → $22 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $7.82
- Market Cap
- $684.23 million
- 52-Week Range
- $6.65 – $36.26
- Average Volume
- 1.17 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.